Figure 3. Expression of oligodendrocyte-specific cell type markers in F3.Olig2 cells and expression of motor neuron-specific cell type markers in F3.Olig2-Shh cells.
Image credit: Lee, 2014 under CC BY license

Meeting Calendar

Newly Added:

A Workshop on Therapeutic Development for Nervous System Disorders in the Absence of Predictive Animal Models of Disease
Washington, DC
September 12-13, 2016

The ENCALS satellite meeting
Dublin, Ireland
December 6, 2016

International Conference on Alzheimer and Parkinson Diseases
Vienna, Austria
March 29 - April 2, 2017


August 2016

International Conference of Frontotemporal Dementias
Description: The ICFTD is now well-recognized as the primary venue for the synthesis, exchange and dissemination of research evidence related to FTD, where experts from diverse backgrounds share recent discoveries, insights and opinions. This allows novel hypotheses to be generated, research collaborations to be established, consensuses to be developed, training opportunities to be explored and knowledge to be translated across disciplines.
Location: Munich, Germany
Date: August 31-September 2, 2016
Abstracts Due: March 31, 2016

September 2016

Neurological Disorders Summit
Description: The 2nd Neurological Disorders Summit will provide a dedicated platform to share cutting-edge scientific findings, medical practices and caregiver initiatives related to various Neurological Disorders. The multidisciplinary meeting will bring together the scientific community - principal investigators, scientists, researchers, health professionals, analysts, clinicians, policy makers, industry experts, the well-established and the budding entrepreneurs to create a worldwide dialogue on various aspects and challenges of devastating neurological conditions.  
Location: Baltimore, MD
Date: September 7-9, 2016
Abstracts Due: April 4, 2016

NEW! A Workshop on Therapeutic Development for Nervous System Disorders in the Absence of Predictive Animal Models of Disease
Sponsor: Forum on Neuroscience and Nervous System Disorders - National Academy of Science - Health and Medicine Division
Description: The Forum on Neuroscience and Nervous System Disorders will host a public workshop to more deeply explore ways to motivate and accelerate drug development for nervous system disorders. The workshop will consider the evidence needed to bring compounds that appear to be safe into human efficacy trials both from an ethical and regulatory point of view and from a pragmatic and financial point of view in the absence of a predictive animal model. The workshop will bring together key stakeholders to discuss scientific, regulatory, and business challenges and to identify potential opportunities in this domain to motivate and accelerate therapeutic development to address unmet medical needs.
Location: Washington, DC
Date: September 12-13, 2016

CNS Diseases World Summit
Sponsor: Global Technology Community (GTC)
Description: The CNS Diseases World Summit provides an interactive learning and relationship-building forum for all players in the CNS field. Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures. The Summit consists of two, back-to-back conferences: 10th Neurodegenerative Conditions Research & Development and 9th CNS Partnering & Deal-Making
Location: Boston, MA
Date: September 12-15, 2016
Abstracts Due: August 12, 2016

European CNS Summit 2016
Description: The European CNS Summit 2016 will have an exclusive focus on empowering translational research in the field of neurodegeneration. This is an opportunity to engage with the thought leaders in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies. We will use this collaborative format to address key challenges facing this field from the translatability of modelling systems to the development of cost effective, non-invasive biomarkers and novel therapeutic strategies for targeting neurodegeneration
Location: London, UK
Date: September 12-14, 2016

Neurodegenerative Conditions Research and Development Conference
Sponsor: Global Technology Community (GTC)
Description: The drug discovery effort for neurodegenerative diseases has been one of the major challenges of the pharmaceutical industry. This conference will connect scientists and researchers to share perspectives on the latest topics of interest, such as targeted treatments for psychiatric disorders, neuroinflammation, and cell- and gene-therapy based therapies. This program strives to encourage dialogue around issues that need to be addressed in order to push research forward into the future: What are the best models of private/public partnerships? How are patient advocacy groups changing the way we think about funding and research?
Location: Boston, MA
Date: September 12-13, 2016
Abstracts Due: August 12, 2016

Molecular Mechanisms of Axon Degeneration
Sponsor: The Jackson Laboratory
Description: The 6th Molecular Mechanisms of Axon Degeneration Meeting will provide participants with leading edge research information regarding axon degeneration as a primary pathogenic mechanism across numerous diseases. The meeting will focus on the basic molecular and cellular mechanisms of axon degeneration, with an emphasis on links between degeneration and broader questions of axon biology including axon transport, metabolism, development, regeneration, axon/glial interactions, and disease.
Location: Bar Harbor, ME
Date: September 25-28, 2016

International Congress of Neuroimmunology (ISNI)
Sponsor: International Society of Neuroimmunology (ISNI)
Description: The brain and the CNS in one hand, and the immune system on the other, have become a major foci of interest in Medicine and Research during the last decades. The exciting developments in the field of Neuroimmunology have substantially revolutionised our understanding of the pathogenesis and immunotherapy of neuroimmune diseases, utilising new and novel technologies in research and clinical applications. Topics discussed in the congress will go beyond traditional neuroimmune diseases and will include neuroinflammation in ALS, immunity in neurodegeneration, CNS microglia and macrophages in health and disease, repair/regeneration, stem cells and neuroimmunomodulation and more.  
Location: Jerusalem, Israel
Date: September 26-29, 2016
Abstracts Due: July 31, 2016

October 2016

International Congress of the World Muscle Society
Sponsor: World Muscle Society
Description: The 21st International Congress of the World Muscle Society will focus on structural myopathies and diseases of the sarcomere, adult onset myopathies and advances in the treatment of neuromuscular disorders.
Location: Granada, Spain
Date: October 4-8, 2016
Abstracts Due: April 3, 2016

Annual NEALS Meeting 2016
Sponsor: Northeast Amytrophic Lateral Sclerosis Consortium (NEALS)
Description: More details available soon!
Location: Clearwater Beach, FL
Date: October 5-7, 2016

American Neurological Association Annual Meeting
Sponsor: American Neurological Association (ANA)
Description: The ANA’s 141st Annual Meeting will features five major symposia which highlight groundbreaking conceptual and therapeutic advances in a variety of neurologic disease states, as well as interactive educational sessions designed to both support career development and provide educational opportunities in sub-specialties.
Location: Baltimore, MD
Date: October 16-18, 2016
Abstracts Due: March 25, 2016

The Lancet Neurology Conference on Preclinical Neurodegenerative Disease
Sponsor: The Lancet
Description: The Lancet Neurology Conference on Preclinical Neurodegenerative Disease: Towards Prevention and Early Diagnosis. The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological state of disease. Researchers are now focusing on preventing and stopping the pathological processes in the brain at an earlier, asymptomatic state. This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases—including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. The event will have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions.
Location: London, UK
Date: October 19-21, 2016
Abstracts Due: June 3, 2016

November 2016

The ALS Association 2016 Clinical Conference
Sponsor: The ALS Association
Description: This conference will be a two-day clinical conference for allied health professionals, clinic coordinators, practice administrators and social workers. The conference will focus on exchanging information on best practices and emerging trends in ALS care.  Updates on adaptive technologies, respiratory devices, options for augmentative communication, end-of-life, psychological and allied health issues will also be featured.
Location: San Diego, California
Date: November 2-4, 2016
Abstracts Due: May 27, 2016

Brain Research Conference, RNA Metabolism in Neurological Disease
Description: The 11th Brain Research Conference and the 4th RNA Metabolism in Neurological Disease Conference will be held as satellites to the 2016 Meeting of the Society for Neuroscience (SfN). This two-day symposium will bring together basic and clinical scientists to discuss the role of perturbed RNA metabolism in neurological diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), spinal muscular atrophy (SMA), and repeat expansion disorders.
Location: San Diego, CA
Date: November 10-11, 2016
Abstracts Due: July 1, 2016

Society for Neuroscience Annual Meeting
Description: SfN's 46th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, collaborate with peers, explore new tools and technologies, and advance careers.
Location: San Diego, CA
Date: November 12-16, 2016
Abstracts Due: May 5, 2016

Cold Spring Harbor Meeting on Neurodegenerative Diseases
Sponsor: Cold Spring Harbor Laboratory
Description: A primary goal of the meeting is to provide a forum where medical scientists from academia can interact with scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for neurodegenerative diseases has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia and industry meet regularly to exchange data and ideas.
Location: Cold Spring Harbor, NY
Date: November 30 - December 3, 2016
Abstracts Due: September 16, 2016

December 2016

Annual ALS Alliance Meeting
Sponsor: International Alliance of ALS/MND Associations
Description: The Annual Meeting of the International Alliance of ALS/MND Associations brings together ALS/MND associations from around the world to share initiatives and develop strategies for fighting ALS/MND and serving people who live with the disease. Attendance is encouraged for all Alliance members, and people living with ALS/MND are welcomed as participants or observers. A Call for Presentations will be distributed in May, with a deadline in July.  
Location: Dublin, Ireland
Date: December 4-5, 2016

NEW! The ENCALS satellite meeting
Sponsor: European Network for the Cure of ALS (ENCALS )
The ENCALS satellite meeting 2016 will be held prior to the 26th MND conference in Dublin. Topic: Large scale phenotyping.

Location: Dublin, Ireland
Date: December 6, 2016
Abstracts Due: November 1, 2016

International Symposium on ALS/MND
Sponsor: Motor Neurone Disease Association (MNDA)
Description: The International Symposium on ALS/MND is a unique annual event that brings together leading international researchers and health and social care professionals to present and debate key innovations in their respective fields. The symposium is planned as two parallel meetings, one on biomedical research and the other on advances in the care and management of people affected by ALS/MND. Joint sessions consider issues of mutual concern, challenging current views and practices.
Location: Dublin, Ireland
Date: December 7-9, 2016
Abstracts Due: May 27, 2016


March 2017

World Congress on Controversies in Neurology (CONy)
Description: In recent years the field of neurology has witnessed enormous expansion in clinical and basic data. CONy provides a platform for international experts to discuss, compare experiences and debate unresolved issues. The Congress aims at providing the most available relevant data armoring the clinician with reliable, up-to-date scientific information, helping in everyday patient care.
Location: Athens, Greece
Date: March 23-26, 2017
Abstracts Due: January 4, 2017

International Neuroscience Winter Conference
Description: Call for proposals for symposia for the 19th International Neuroscience Winter Conference is now open, the deadline for proposals submission is September 1st, 2016.  
Location: Solden, Austria
Date: March 26-30, 2017
Abstracts Due: February 10, 2016

NEW! International Conference on Alzheimer and Parkinson Diseases
Description: The 13th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases. AD/PD Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention and therapy.
Location: Vienna, Austria
Date: March 29 - April 2, 2017
Abstracts Due: September 29, 2016

May 2017

Annual ENCALS Meeting 2017
Sponsor: European Network for the Cure of ALS (ENCALS )
Location: Ljubljana, Slovenia
Date: May 25-27, 2017

July 2017

European Meeting on Glial Cells in Health and Disease
Sponsor: Network Glia
Description: The XIII European Meeting on Glial Cell Function in Health and Disease is the world’s largest and most comprehensive scientific gathering on glial cell biology and medicine.
Location: Edinburgh, Scotland
Date: July 8-11, 2017
Abstracts Due: February 1, 2017

September 2017

4th Ottawa International Conference on Neuromuscular Disease and Biology
Sponsor: University of Ottawa - Centre for Neuromuscular Disease
Description: The Conference is structured for both basic researchers and clinicians and will feature internationally-recognized invited speakers highlighting advances in all aspects of NMD research, including novel techniques to diagnose NMD, biology of disease pathogenesis, expanding clinical phenotypes, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Registration will open Spring 2017.
Location: Ottawa, Ontario, Canada
Date: September 7-9, 2017

World Congress of Neurology 2017
Sponsor: World Federation of Neurology (WFN)
Description: More details available soon!
Location: Kyoto, Japan
Date: September 16-21, 2017

November 2017

Society for Neuroscience Annual Meeting
Description: The Society for Neuroscience (SFN)'s 47th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, collaborate with peers, explore new tools and technologies, and advance careers.
Location: Washington, DC
Date: November 11-15, 2017
Abstracts Due: May 6, 2016

Share this: